Press Release / Apr 15, 2009
TwinCaps® in Phase III clinical trials for influenza
Hovione’s TwinCaps® inhaler in Phase III clinical trials for influenza
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
Hovione’s TwinCaps® inhaler in Phase III clinical trials for influenza
Pharmaceutical Technology Sourcing and Management, July 2006
Pharmaceutical Technology Europe, February 2014
Drug Delivery Technology, April 2007
Learn more about Hovione portfolio of API for Inhalation
Development by Design is Hovione’s proven spray-dried dispersion scale-up and tech-transfer methodology.